During the past 15 years, our institute has performed a series of clinical trials of cytokine-based cell therapy, named the MAGIC cell (Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intracoronary Stem Cell Infusion) trial. The gene discussed is CSF3; the disease is myocardial infarction.